Dicerna Pharmaceuticals Inc reports

Company location: Lexington, MA
Fiscal year end: 31 December

Dicerna Pharmaceuticals Inc has filed 657 SEC EDGAR filings since 01 May 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-25 of 656 matching filings.

Per page

25

Current page

1

SC 13G/A File 005-87866

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

15-12B File 001-36281

FORM 15-12B

Filing date: 10 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-224989

EFFECT filing

Filing date: 30 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-223778

EFFECT filing

Filing date: 30 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-214082

EFFECT filing

Filing date: 30 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-202687

EFFECT filing

Filing date: 30 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

POSASR File 333-234572

POSASR

Filing date: 28 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-224989

POS AM

Filing date: 28 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-223778

POS AM

Filing date: 28 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-214082

POS AM

Filing date: 28 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .